R. Temaru

522 total citations
10 papers, 445 citations indexed

About

R. Temaru is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, R. Temaru has authored 10 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 4 papers in Molecular Biology and 4 papers in Epidemiology. Recurrent topics in R. Temaru's work include Adipokines, Inflammation, and Metabolic Diseases (4 papers), Atherosclerosis and Cardiovascular Diseases (4 papers) and Lipoproteins and Cardiovascular Health (2 papers). R. Temaru is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (4 papers), Atherosclerosis and Cardiovascular Diseases (4 papers) and Lipoproteins and Cardiovascular Health (2 papers). R. Temaru collaborates with scholars based in Japan. R. Temaru's co-authors include Masaharu Urakaze, Masashi Kobayashi, Mika Kishida, Katsuya Yamazaki, Akira Sato, Tohru Funahashi, Shinji Kihara, Norio Nakamura, Norio Nakamura and Chikaaki Kobashi and has published in prestigious journals such as Circulation Research, Diabetologia and British Journal of Pharmacology.

In The Last Decade

R. Temaru

10 papers receiving 426 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Temaru Japan 9 221 135 102 101 91 10 445
Mika Kishida Japan 8 202 0.9× 103 0.8× 75 0.7× 86 0.9× 77 0.8× 9 387
Rajesh K. Davda United States 8 103 0.5× 162 1.2× 181 1.8× 84 0.8× 105 1.2× 12 556
Jorge Plutzky United States 5 131 0.6× 71 0.5× 88 0.9× 103 1.0× 141 1.5× 5 437
Atsuko Tomizawa Japan 8 178 0.8× 107 0.8× 75 0.7× 79 0.8× 173 1.9× 9 430
Takashi Shimotomai Japan 10 180 0.8× 73 0.5× 75 0.7× 79 0.8× 113 1.2× 13 534
Seitarou Omoto Japan 8 108 0.5× 49 0.4× 148 1.5× 76 0.8× 156 1.7× 8 406
Yoshinori Tsuchiyama Japan 8 85 0.4× 113 0.8× 121 1.2× 92 0.9× 235 2.6× 12 576
Rogelio A. Machado Argentina 7 68 0.3× 110 0.8× 193 1.9× 64 0.6× 130 1.4× 18 535
Xuezeng Xu China 13 175 0.8× 70 0.5× 135 1.3× 51 0.5× 155 1.7× 26 541
Naomi Yoshioka Japan 7 137 0.6× 55 0.4× 57 0.6× 67 0.7× 75 0.8× 7 439

Countries citing papers authored by R. Temaru

Since Specialization
Citations

This map shows the geographic impact of R. Temaru's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Temaru with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Temaru more than expected).

Fields of papers citing papers by R. Temaru

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Temaru. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Temaru. The network helps show where R. Temaru may publish in the future.

Co-authorship network of co-authors of R. Temaru

This figure shows the co-authorship network connecting the top 25 collaborators of R. Temaru. A scholar is included among the top collaborators of R. Temaru based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Temaru. R. Temaru is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Usui, Isao, Shiho Fujisaka, Katsuya Yamazaki, et al.. (2007). Telmisartan reduced blood pressure and HOMA-IR with increasing plasma leptin level in hypertensive and type 2 diabetic patients. Diabetes Research and Clinical Practice. 77(2). 210–214. 52 indexed citations
2.
Kishida, Mika, Masaharu Urakaze, Miyako Takata, et al.. (2005). PGE1 Inhibits the Expression of PAI-1 mRNA Induced by TNF-α in Human Mesangial Cells. Experimental and Clinical Endocrinology & Diabetes. 113(7). 365–371. 8 indexed citations
3.
Kobashi, Chikaaki, Masaharu Urakaze, Mika Kishida, et al.. (2005). Adiponectin Inhibits Endothelial Synthesis of Interleukin-8. Circulation Research. 97(12). 1245–1252. 212 indexed citations
4.
Urakaze, Masaharu, R. Temaru, Akira Sato, et al.. (2002). α-Tocopherol Inhibits IL-8 Synthesis Induced by Thrombin and High Glucose in Endothelial Cells. Hormone and Metabolic Research. 34(2). 49–54. 16 indexed citations
5.
Urakaze, Masaharu, R. Temaru, Katsuya Yamazaki, et al.. (2001). Pravastatin suppresses the interleukin‐8 production induced by thrombin in human aortic endothelial cells cultured with high glucose by inhibiting the p44/42 mitogen activated protein kinase. British Journal of Pharmacology. 134(4). 753–762. 38 indexed citations
6.
Sato, Akira, Toshiyasu Sasaoka, Katsuya Yamazaki, et al.. (2001). Glucosamine enhances platelet-derived growth factor-induced DNA synthesis via phosphatidylinositol 3-kinase pathway in rat aortic smooth muscle cells. Atherosclerosis. 157(2). 341–352. 6 indexed citations
7.
Nakamura, Norio, Tomohito Hamazaki, Masayuki Ohta, et al.. (1999). Joint effects of HMG-CoA reductase inhibitors and eicosapentaenoic acids on serum lipid profile and plasma fatty acid concentrations in patients with hyperlipidemia. International Journal of Clinical & Laboratory Research. 29(1). 22–25. 40 indexed citations
9.
Takada, Yoshihisa, Yasumitsu Takata, Masanori Iwanishi, et al.. (1996). Effect of glimepiride (HOE 490) on insulin receptors of skeletal muscles from genetically diabetic KK-Ay mouse. European Journal of Pharmacology. 308(2). 205–210. 15 indexed citations
10.
Temaru, R., et al.. (1996). The IL-8 Production in Endothelial Cells is Stimulated by High Glucose. Hormone and Metabolic Research. 28(8). 400–401. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026